The cessation of ovarian function triggers menopause which signifies the conclusion of the female reproductive years. The Synaptonemal Complex Protein 2-Like protein (SYCP2L) functions as a vital component in the aging mechanisms of the female reproductive system. The human SYCP2L genetic locus displays associations with the timing of natural menopause in women. SYCP2L functions as a SYCP2 paralog while its C-terminal part is essential for centromeric targeting of SYCP2L in oocytes but this part gets lost in SYCP2L variants with low-frequency nonsense mutations found in humans.
Related Product
Function of SYCP2L
SYCP2L is a meiosis-related protein and a member of the centromere complex. Although it has "centromere" in its name, it does not directly act on the centromere and is actively expressed during oocyte meiosis.
- Chromosome synapsis: helps homologous chromosomes pair correctly during meiosis I.
-
Gene recombination: promotes gene exchange and provides genetic diversity for the next generation.
-
Meiotic progression: Maintaining the stable progress of meiosis is a key step in oocyte maturation.
SYCP2L Reveals the Key to Female Reproductive Clock
| Project |
Description |
| Main function |
Assists in chromosome pairing and meiosis |
| Key role |
Follicular development, oocyte maintenance and stability |
| Abnormal consequences |
Premature ovarian failure, premature termination of female fertility |
| Medical value |
New reproductive disease markers and therapeutic targets |
The Link between SYCP2L and Aging of Female Reproductive System
Gene Mutations Lead to Premature Ovarian Failure (POI)
Women who experience ovarian function failure before turning 40 years old experience Primary Ovarian Insufficiency (POI) with symptoms including amenorrhea and infertility and abnormal hormone levels. Research indicates that mutations in the SYCP2L gene or its functional loss directly cause POI. Patients with functional SYCP2L mutations had a protein that could not perform its typical role in meiosis which led to follicular apoptosis.
Accelerated Depletion of Follicular Reserves
When SYCP2L stops working properly it causes premature failure in follicle development or speeds up apoptosis. A woman's finite follicle supply means that early depletion results in the reproductive system aging prematurely.
Impaired Chromosome Stability
When SYCP2L is lost cells experience chromosome pairing mistakes during meiosis trigger cellular death mechanisms including DNA damage response which results in oocyte death. The dysfunction of SYCP2L protein provides a molecular explanation for the faster deterioration of ovarian function in women as they age.
Results of SYCP2L Dysfunction
SYCP2L is a protein that plays an important role in meiosis. The protein is closely related to chromosome synapsis during meiosis and is involved in the correct pairing and recombination of homologous chromosomes, which is essential for the normal formation of eggs or sperm. In women, SYCP2L deficiency may cause the following fertility problems:
| Abnormalities |
Consequences |
| Meiotic failure |
Chromosome nondisjunction → embryonic development failure |
| Homologous pairing disorder |
DNA damage accumulation → oocyte apoptosis |
| Follicular depletion |
Infertility, irregular menstruation, premature menopause |
| Hormonal disturbances |
Decrease in estrogen levels → osteoporosis, increased risk of cardiovascular disease |
- Abnormal oocyte development: The failure of chromosomes to pair and recombine properly prevents oocytes from completing meiosis and leads to the production of immature or defective eggs.
- Diminished ovarian reserve (DOR): Mutations in SYCP2L cause reduced ovarian reserve function as evidenced by a lower follicle count according to scientific studies.
- Primary ovarian insufficiency (POI): Severe defects cause primary ovarian insufficiency (POI) as they trigger premature ovarian decline in women under 40 years old.
- Infertility: Poor quality or low quantity of eggs leads to decreased pregnancy possibilities.
Potential Intervention and Treatment Directions
Gene Screening and Diagnosis
Women who have a family history or experience unexplained infertility can benefit from SYCP2L mutation screening by receiving early medical interventions.
Gene Editing Technology
Repairing SYCP2L mutations might allow us to "reverse" ovarian function or postpone aging in future medical advancements.
Hormonal Replacement Therapy Assistance
HRT serves as a treatment to alleviate symptoms of hormone decline from SYCP2L mutations while also preventing osteoporosis.
Stem Cells and Regenerative Medicine
Stem cell treatment offers fresh possibilities for rebuilding follicle structure and function to treat premature ovarian failure.
The study of SYCP2L has revealed a long-neglected mechanism of female aging: The research surrounding SYCP2L clarifies the molecular reasons behind why certain women experience early reproductive aging. Future research in precision medicine focused on SYCP2L will work to decelerate reproductive system aging and boost both reproductive health and quality of life in females.
References
- He, W., et al. Homozygous variants in SYCP2L cause premature ovarian insufficiency. Journal of medical genetics. 2021, 58(3): 168-172.
- Rosa, I., et al. Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study. JBRA Assisted Reproduction. 2023, 27(3): 428.
.
